Hover a dot or row, or tab through the dots · bars scaled to the largest round ($4.1M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-502978
First filed2024-01-19
Latest2024-01-19
Sought$6.6M
Sold$4.1M
Investors1
Exemptions506(b)
Who backs Aether Therapeutics Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-01-19
Related persons
Name
Relationship
John D Harris
RelationshipExecutive Officer, Director
Jon S Saxe
RelationshipExecutive Officer, Director
Wolfgang Sadee
RelationshipDirector
Eric K Olson
RelationshipDirector
Sales compensation
Named in Item 12 of its Form D filings
Sales compensation recipients
Recipient
CRD
Broker-dealer
Offerings
Issuer Direct Sales Only
CRD—
Broker-dealer—
Offerings1
Facts
As its latest Form D states them
Industry
Biotechnology
State
Texas (TX)
Exemptions
Rule 506(b)
First filed
2024-01-19
Latest filing
2024-01-19
Minimum investment
$50K
Who backs Aether Therapeutics Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)